通过专为投资者打造的一站式数据看板，全面查看 Werewolf Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

48.07M

股息TTM

0.00

市盈率 TTM

-0.82

每股收益TTM

-1.20

营业收入

0.00

净利润

-70.52M

净资产收益率

-161.89%

总资产收益率

-68.09%

Werewolf Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

财务指标

每股收益

118.89%0.08

31.00%-0.28

62.28%-0.17

6.32%-0.36

-0.87%-0.40

-3.68%-0.40

-39.76%-0.46

-64.19%-0.38

-176.44%-0.40

-12.99%-0.39

15.41%-0.33

---0.23

---0.14

---0.34

---0.39

----

营业收入

--21.00M

--0.00

-100.00%0.00

-85.86%1.14M

-83.38%742.00K

-79.39%1.50M

18.65%5.90M

94.82%8.08M

--4.46M

--7.28M

--4.97M

--4.15M

----

净利润

120.41%3.67M

25.19%-13.53M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-69.96%-20.40M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

-0.61%-12.00M

30.63%-8.29M

65.07%-5.10M

21.91%-11.98M

33.24%-11.93M

13.19%-11.94M

78.49%-14.59M

85.02%-15.34M

13.04%-17.87M

-126.73%-13.76M

利润率

--17.48%

----

-2292.12%-1509.10%

-713.05%-2182.35%

-388.18%-799.67%

---140.50%

---63.09%

---268.41%

---163.81%

----

毛利率

--100.00%

----

0.00%100.00%

--100.00%

----

资产负债率

-100.00%0.00%

100.43%49.69%

97.91%40.69%

89.86%34.73%

78.86%29.28%

11.71%24.79%

-8.59%20.56%

-17.75%18.29%

-22.53%16.37%

10.83%22.19%

--22.49%

--22.24%

--21.13%

--20.03%

--0.00%

----

利润表

营业收入

--21.00M

--0.00

-100.00%0.00

-85.86%1.14M

-83.38%742.00K

-79.39%1.50M

18.65%5.90M

94.82%8.08M

--4.46M

--7.28M

--4.97M

--4.15M

----

营业利润

148.67%8.54M

50.16%-8.97M

53.72%-9.42M

8.16%-15.73M

7.48%-17.54M

-4.83%-17.99M

-56.98%-20.35M

-85.10%-17.12M

-212.51%-18.96M

-40.41%-17.16M

1.65%-12.96M

26.22%-9.25M

59.48%-6.07M

20.45%-12.22M

26.31%-13.18M

9.10%-12.54M

-36.66%-14.97M

-106.20%-15.37M

-141.94%-17.88M

-127.90%-13.79M

净利润

120.41%3.67M

25.19%-13.53M

58.92%-8.38M

1.82%-16.37M

-4.25%-17.98M

-11.71%-18.09M

-69.96%-20.40M

-101.24%-16.67M

-238.35%-17.25M

-35.14%-16.19M

-0.61%-12.00M

30.63%-8.29M

65.07%-5.10M

21.91%-11.98M

33.24%-11.93M

13.19%-11.94M

78.49%-14.59M

85.02%-15.34M

13.04%-17.87M

-126.73%-13.76M

资产负债表

流动资产

-71.54%22.89M

-48.41%48.73M

-48.18%58.59M

-45.82%68.17M

-42.04%80.44M

-33.61%94.46M

-18.29%113.07M

-9.64%125.83M

-5.84%138.79M

-9.12%142.28M

-1.31%138.37M

-8.13%139.26M

-4.39%147.40M

7.65%156.56M

-12.96%140.20M

-13.08%151.59M

-17.28%154.16M

71.37%145.44M

--161.07M

--174.40M

流动负债总额

-48.17%7.86M

230.10%38.52M

138.13%36.15M

41.23%17.60M

32.59%15.17M

-44.99%11.67M

-21.66%15.18M

-13.68%12.46M

-23.75%11.44M

-2.34%21.21M

-19.22%19.38M

-48.06%14.44M

-50.59%15.01M

96.97%21.72M

102.03%23.99M

257.56%27.80M

312.05%30.37M

103.88%11.03M

--11.87M

--7.78M

总资产

-73.91%24.16M

-45.89%58.02M

-45.33%69.40M

-43.14%79.63M

-39.78%92.57M

-39.62%107.24M

-27.40%126.93M

-20.61%140.04M

-17.02%153.70M

-8.96%177.60M

9.10%174.83M

2.30%176.39M

5.65%185.24M

18.49%195.07M

-10.60%160.25M

-3.34%172.42M

-7.92%175.33M

84.08%164.63M

--179.25M

--178.38M

总负债

-84.61%7.86M

-8.23%45.82M

-16.71%44.59M

-1.27%50.01M

2.85%51.10M

-16.80%49.93M

-15.63%53.54M

-20.78%50.66M

-25.44%49.69M

-18.90%60.01M

67.40%63.46M

54.16%63.94M

46.49%66.64M

192.32%74.00M

43.25%37.91M

357.20%41.48M

413.29%45.49M

256.92%25.31M

--26.46M

--9.07M

总权益

-60.71%16.29M

-78.71%12.20M

-66.20%24.80M

-66.87%29.61M

-60.14%41.46M

-51.26%57.31M

-34.10%73.39M

-20.51%89.38M

-12.29%104.02M

-2.88%117.59M

-8.96%111.37M

-14.13%112.44M

-8.66%118.60M

-13.10%121.07M

-19.93%122.34M

-22.66%130.95M

-28.48%129.84M

69.19%139.32M

--152.79M

--169.30M

现金流量表

经营净额

143.72%6.63M

44.07%-10.60M

22.65%-11.02M

-21.62%-15.16M

-6.96%-15.16M

-23.87%-18.95M

-210.84%-14.25M

-72.89%-12.46M

-29.81%-14.18M

-54.55%-15.30M

61.37%-4.58M

50.19%-7.21M

-3504.29%-10.92M

29.05%-9.90M

6.34%-11.87M

-16.55%-14.47M

97.10%-303.00K

-90.43%-13.95M

-110.90%-12.67M

-152.33%-12.42M

投资净额

--416.00K

----

100.00%0.00

37.88%-123.00K

98.64%-3.00K

90.66%-17.00K

33.93%-111.00K

61.78%-198.00K

88.69%-221.00K

83.62%-182.00K

-500.00%-168.00K

-90.44%-518.00K

-1815.69%-1.95M

-900.90%-1.11M

-115.38%-28.00K

-2922.22%-272.00K

-78.95%-102.00K

融资净额

-8453.61%-32.41M

----

-7.11%2.37M

54666.67%3.27M

103.99%388.00K

-100.00%0.00

-71.93%2.55M

-114.63%-6.00K

-1504.62%-9.72M

-58.33%20.26M

622.37%9.07M

-99.63%41.00K

-79.74%692.00K

30480.50%48.62M

3205.26%1.26M

4113.04%11.08M

-96.90%3.42M

129.55%159.00K

-99.95%38.00K

-184.54%-276.00K

常见问题

Werewolf Therapeutics Inc的流动资产是多少？



根据Werewolf Therapeutics Inc的FY2025财报，流动资产为58.59M（同比变化-48.18）。

Werewolf Therapeutics Inc的总资产是多少？



根据Werewolf Therapeutics Inc的FY2025财报，Werewolf Therapeutics Inc的总资产为69.40M（同比变化-45.33）。

Werewolf Therapeutics Inc的总负债是多少？



根据Werewolf Therapeutics Inc的FY2025财报，Werewolf Therapeutics Inc的总负债为44.59M（同比变化-16.71）。

Werewolf Therapeutics Inc的总权益是多少？



根据Werewolf Therapeutics Inc的FY2025财报，Werewolf Therapeutics Inc的总权益为24.80M（同比变化-66.20）。

Werewolf Therapeutics Inc的净营业收入是多少？



根据Werewolf Therapeutics Inc的FY2025财报，Werewolf Therapeutics Inc的净营业收入为-60.68M（同比变化17.55）。

Werewolf Therapeutics Inc的净融资是多少？



根据Werewolf Therapeutics Inc的FY2025财报，Werewolf Therapeutics Inc的净融资为6.03M（同比变化-53.91）。

Werewolf Therapeutics Inc的每股收益（EPS）是多少？



根据Werewolf Therapeutics Inc的FY2025财报，每股收益（EPS）为-1.32（同比变化18.78）。

Werewolf Therapeutics Inc的净利润是多少？



根据Werewolf Therapeutics Inc的FY2025财报，净利润为-60.82M（同比变化13.75）。

Werewolf Therapeutics Inc的债务与资产比率是多少？



根据Werewolf Therapeutics Inc的FY2025财报，债务与资产比率为40.69（同比变化97.91）。

Werewolf Therapeutics Inc的股东权益回报率（ROE）是多少？



根据Werewolf Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-123.88（同比变化-62.30）。

Werewolf Therapeutics Inc的资产回报率（ROA）是多少？



根据Werewolf Therapeutics Inc的FY2025财报，资产回报率（ROA）为-61.96（同比变化-32.58）。

Werewolf Therapeutics Inc的营业利润是多少？



根据Werewolf Therapeutics Inc的FY2025财报，营业利润为-60.68M（同比变化17.55）。